Neuroscientists Discover New Group of Brain Cells

This discovery highlights the complex interaction between the brainstem and basal ganglia in movement control. Scientists have identified a group of brain cells in mice that facilitate their ability to turn right or left. This finding could potentially be applied in future treatments for Parkinson’s disease, the journal Nature Neuroscience reported.

Have you ever wondered what happens in the brain when we move to the right or left? Most people don’t; they simply perform these movements automatically. However, this seemingly straightforward action is governed by a complex process.

In a new study, researchers have discovered the missing piece in the complex nerve-network needed for left-right turns. The discovery was made by a research team consisting of Assistant Professor Jared Cregg, Professor Ole Kiehn, and their colleagues from the Department of Neuroscience at the University of Copenhagen.

In 2020, Ole Kiehn, Jared Cregg, and their colleagues identified the ‘brain’s steering wheel’ – a network of neurons in the lower part of the brainstem that commands right- and left- movements when walking. At the time, though, it was not clear to them how this right-left circuit is controlled by other parts of the brain, such as the basal ganglia.

“We have now discovered a new group of neurons in the brainstem which receives information directly from the basal ganglia and control the right-left circuit,” Ole Kiehn explains.

Eventually, this discovery may be able to help people suffering from Parkinson’s disease. The study has been published in the esteemed scientific journal Nature Neuroscience.

The basal ganglia are located deep within the brain. For many years now, they have been known to play a key role in controlling voluntary movements.

Years ago, scientists learned that by stimulating the basal ganglia you can affect right- and left-hand movements in mice. They just did not know how.

“When walking, you will shorten the step length of the right leg before making a right-hand turn and the left leg before making a left-hand turn. The newly discovered network of neurons is located in a part of the brainstem known as PnO. They are the ones that receive signals from the basal ganglia and adjust the step length as we make a turn, and which thus determine whether we move to the right or left,” Jared Cregg explains.

The study therefore provides a key to understanding how these absolutely essential movements are produced by the brain.

In the new study, the researchers studied the brain of mice, as their brainstem closely resembles the human brainstem. Therefore, the researchers expect to find a similar right-left circuit in the human brain.

Parkinson’s disease is caused by a lack of dopamine in the brain. This affects the basal ganglia, and the researchers responsible for the new study believe that this leads to failure to activate the brainstem’s right-left circuit.

And it makes sense when you look at the symptoms experienced by people with Parkinson’s at a late stage of the disease – they often have difficulties turning when walking.

In the new study, the researchers have studied this in mice with symptoms resembling those of people with Parkinson’s disease. They made the so-called Parkinson’s model, removing dopamine from the brain of mice and thus giving them motor symptoms similar to those experienced by people suffering from Parkinson’s disease

“These mice had difficulties turning, but by stimulating the PnO neurons we were able to alleviate turning difficulties,” Jared Cregg says.

Using Deep Brain Stimulation, scientists may eventually be able to develop similar stimulation for humans. At present, though, they are unable to stimulate human brain cells as accurately as in mice models, where they used advanced optogenetic techniques.

“The neurons in the brainstem are a mess, and electric stimulation, which is the type of stimulation used in human Deep Brain Stimulation, cannot distinguish the cells from one another. However, our knowledge of the brain is constantly growing, and eventually, we may be able to start considering focused Deep Brain Stimulation of humans,” Ole Kiehn concludes.

4155/v